Ebola medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


The treatment of Ebola infection is primarily supportive and includes maintaining [[fluids]] and [[electrolytes]] [[homeostasis]], adequate [[oxygen]] levels and [[blood pressure]] and treating any complicating infections.<ref name=CDC>{{cite web | title = CDC Ebola Hemorrhagic Fever Information Packet | url = http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/Fact_Sheets/Ebola_Fact_Booklet.pdf }}</ref> All patients with a confirmed or suspected viral hemorrhagic fever should be put in isolation and adequate contact precautions.<ref name="pmid21084112">{{cite journal| author=Feldmann H, Geisbert TW| title=Ebola haemorrhagic fever. | journal=Lancet | year= 2011 | volume= 377 | issue= 9768 | pages= 849-62 | pmid=21084112 | doi=10.1016/S0140-6736(10)60667-8 | pmc=PMC3406178 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21084112  }} </ref> No vaccine is currently available.
The treatment of Ebola infection is primarily supportive and includes maintaining [[fluids]] and [[electrolytes]] [[homeostasis]], adequate [[oxygen]] levels and [[blood pressure]] and treating any complicating infections.<ref name=CDC>{{cite web | title = CDC Ebola Hemorrhagic Fever Information Packet | url = http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/Fact_Sheets/Ebola_Fact_Booklet.pdf | year = April 2010 }}</ref> All patients with a confirmed or suspected viral hemorrhagic fever should be put in isolation and adequate contact precautions.<ref name="pmid21084112">{{cite journal| author=Feldmann H, Geisbert TW| title=Ebola haemorrhagic fever. | journal=Lancet | year= 2011 | volume= 377 | issue= 9768 | pages= 849-62 | pmid=21084112 | doi=10.1016/S0140-6736(10)60667-8 | pmc=PMC3406178 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21084112  }} </ref> No vaccine is currently available.


==Medical Therapy==
==Medical Therapy==

Revision as of 15:24, 29 June 2014

Ebola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ebola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Algorithm for the Evaluation of the Returned Traveler

Emergency Department Evaluation

Case Definition

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Hospital Preparedness

Checklists

Air Medical Transport

Monitoring and Movement Following Exposure

Primary Prevention

Future or Investigational Therapies

Postmortem Care

Postmortem Care

Case Studies

Case #1

Ebola medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebola medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebola medical therapy

CDC on Ebola medical therapy

Ebola medical therapy in the news

Blogs on Ebola medical therapy

Directions to Hospitals Treating ebola

Risk calculators and risk factors for Ebola medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Guillermo Rodriguez Nava, M.D. [2]

Overview

The treatment of Ebola infection is primarily supportive and includes maintaining fluids and electrolytes homeostasis, adequate oxygen levels and blood pressure and treating any complicating infections.[1] All patients with a confirmed or suspected viral hemorrhagic fever should be put in isolation and adequate contact precautions.[2] No vaccine is currently available.

Medical Therapy

Treatment is primarily supportive and includes:

References

  1. "CDC Ebola Hemorrhagic Fever Information Packet" (PDF). April 2010.
  2. Feldmann H, Geisbert TW (2011). "Ebola haemorrhagic fever". Lancet. 377 (9768): 849–62. doi:10.1016/S0140-6736(10)60667-8. PMC 3406178. PMID 21084112.


Template:WH Template:WS